Ryosuke Ogata
Sasebo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 23, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.
Journal: Journal of thoracic disease
Published: May 31, 2025
Successful EGFR Mutation Detection in Cytological Specimens of Lung Cancer with Challenging Biopsies by Integrating Virtual Bronchoscopy Navigation and Endobronchial Ultrasound Guidance with Highly Sensitive Next-Generation Sequencing: A Case Report.
Journal: Case reports in oncology
Published: June 28, 2024
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Journal: Translational lung cancer research
Published: June 15, 2024
Prognostic value of systemic inflammation score in patients with esophageal cancer.
Journal: Annals of medicine and surgery (2012)
Published: December 20, 2023
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Journal: Thoracic cancer
Published: August 16, 2023
Primary Malignant Melanoma of the Esophagus Treated with Surgical Resection at an Early Stage.
Journal: Case reports in gastroenterology
Published: June 07, 2023
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.
Journal: Journal of clinical medicine
Published: August 04, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026